Related Experiment Video
Updated: Oct 24, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to
Gonzalo Saiz-Gonzalo1,2,3, Naomi Hanrahan1,2,3, Valerio Rossini1
1APC Microbiome Ireland, University College Cork, National University of Ireland, Cork, Ireland.
Abstract:
Carcinoembryogenic antigen cellular adhesion molecules (CEACAMs) are intercellular adhesion molecules highly expressed in intestinal epithelial cells. CEACAM1, -3, -5, -6, -7 are altered in patients suffering from colon cancer and inflammatory bowel diseases (IBD), but their role in the onset and pathogenesis of IBD is not well known. Herein, we aim to correlate CEACAM1, -3, -5, -6, -7 expression to the degree of inflammation in pediatric and adult IBD colon biopsies and to examine the regulation of CEACAMs on human intestinal epithelial cell lines (C2BBe1/HT29) by different IBD-associated triggers (cytokines, bacteria/metabolites, emulsifiers) and IBD-drugs (6-Mercaptopurine, Prednisolone, Tofacitinib). Biopsies from patients with pediatric Crohn's disease (CD) and adult ulcerative colitis (UC, active/inactive disease) showed a significant increase in CEACAM3, -5, -6 expression, while CEACAM5 expression was reduced in adult CD patients (active/inactive disease). Intestinal epithelial cells cultured with a pro-inflammatory cytokine cocktail and Adherent-invasive Escherichia coli (AIEC) showed a rapid induction of CEACAM1, -5, -7 followed by a reduced RNA and protein expression overtime and a constant expression of CEACAM3, correlating with IL-8 expression. Cells cultured with the emulsifier polysorbate-80 resulted in a significant induction of CEACAM3, -5, -6, -7 at a late time point, while SCFA treatment reduced CEACAM1, -5, -7 expression. No major alterations in expression of CEACAMs were noted on cells cultured with the commensal Escherichia coli K12 or the pathogen Salmonella typhimurium. IBD drugs, particularly Tofacitinib, significantly reduced cytokine-induced CEACAM1, -3, -5, -6, -7 expression associated with a reduced IL-8 secretion. In conclusion, we provide new evidence on the regulation of CEACAMs by different IBD-associated triggers, identifying a role of CEACAMs in IBD pathogenesis.
Insights
Carcinoembryonic antigen cellular adhesion molecules (CEACAMs) are altered in inflammatory bowel diseases (IBD). This study found CEACAM expression changes in IBD patients and identified triggers and drugs regulating CEACAMs in intestinal cells, revealing their role in IBD pathogenesis.
Area of Science:
- Gastroenterology and Immunology
- Molecular Biology
- Cell Biology
Background:
- Carcinoembryonic antigen cellular adhesion molecules (CEACAMs) are expressed in intestinal epithelial cells.
- CEACAM1, -3, -5, -6, -7 alterations are noted in colon cancer and inflammatory bowel diseases (IBD).
- The specific role of CEACAMs in IBD pathogenesis remains unclear.
Purpose of the Study:
- To correlate CEACAM expression levels with inflammation severity in pediatric and adult IBD.
- To investigate the regulation of CEACAMs by IBD-associated factors in intestinal epithelial cells.
- To examine the effect of IBD drugs on CEACAM expression.
Main Methods:
- Analysis of CEACAM expression in colon biopsies from pediatric Crohn's disease and adult ulcerative colitis patients.
- In vitro studies using human intestinal epithelial cell lines (C2BBe1/HT29) treated with cytokines, bacteria, metabolites, emulsifiers, and IBD drugs.
- Quantitative assessment of CEACAM RNA and protein expression, and IL-8 secretion.
Main Results:
- Increased CEACAM3, -5, -6 expression in pediatric CD and active adult UC; reduced CEACAM5 in adult CD.
- Pro-inflammatory triggers and emulsifiers induced CEACAMs, while SCFAs reduced them.
- IBD drugs, especially Tofacitinib, suppressed cytokine-induced CEACAM expression and IL-8 secretion.
Conclusions:
- CEACAMs are differentially regulated by various IBD-associated triggers in intestinal epithelial cells.
- CEACAM expression patterns correlate with IBD inflammation severity.
- CEACAMs play a significant role in the pathogenesis of inflammatory bowel diseases.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

